Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework
Abstract Exhaled breath samples of lung cancer patients (LC), tuberculosis (TB) patients and asymptomatic controls (C) were analyzed using gas chromatography-mass spectrometry (GC-MS). Ten volatile organic compounds (VOCs) were identified as possible biomarkers after confounders were statistically e...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-11365-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849235407751872512 |
|---|---|
| author | Tlotlo Cassandra Setlhare Atlang Gild Mpolokang Emmanuel Flahaut George Chimowa |
| author_facet | Tlotlo Cassandra Setlhare Atlang Gild Mpolokang Emmanuel Flahaut George Chimowa |
| author_sort | Tlotlo Cassandra Setlhare |
| collection | DOAJ |
| description | Abstract Exhaled breath samples of lung cancer patients (LC), tuberculosis (TB) patients and asymptomatic controls (C) were analyzed using gas chromatography-mass spectrometry (GC-MS). Ten volatile organic compounds (VOCs) were identified as possible biomarkers after confounders were statistically eliminated to enhance biomarker specificity. The diagnostic potential of these possible biomarkers was evaluated using multiple machine learning models and their performance for classifying patients and controls was compared. Partial least squares-discriminant analysis (PLS-DA) emerged as the best-performing model for separating lung cancer from controls, with a recall (sensitivity) of 82%, precision of 90%, accuracy of 80% and F1-score of 86%. To further validate this model, TB data was introduced as a confounding disease, and the model achieved precision, recall, accuracy and F1-score of 88% each, in distinguishing lung cancer from TB. These findings address the inter-disease variability and underscores the reliability of the reported VOCs as potential biomarkers of lung cancer. This study establishes a new framework integrating machine learning and confounder elimination for biomarker confirmation. |
| format | Article |
| id | doaj-art-d19bd997fede435fbe0591f1a49bf8d3 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-d19bd997fede435fbe0591f1a49bf8d32025-08-20T04:02:46ZengNature PortfolioScientific Reports2045-23222025-07-0115111210.1038/s41598-025-11365-4Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis frameworkTlotlo Cassandra Setlhare0Atlang Gild Mpolokang1Emmanuel Flahaut2George Chimowa3Department of Physics and Astronomy, Botswana International University of Science and TechnologyDepartment of Physics and Astronomy, Botswana International University of Science and TechnologyCIRIMAT, Toulouse INP, CNR, Université de ToulouseDepartment of Physics and Astronomy, Botswana International University of Science and TechnologyAbstract Exhaled breath samples of lung cancer patients (LC), tuberculosis (TB) patients and asymptomatic controls (C) were analyzed using gas chromatography-mass spectrometry (GC-MS). Ten volatile organic compounds (VOCs) were identified as possible biomarkers after confounders were statistically eliminated to enhance biomarker specificity. The diagnostic potential of these possible biomarkers was evaluated using multiple machine learning models and their performance for classifying patients and controls was compared. Partial least squares-discriminant analysis (PLS-DA) emerged as the best-performing model for separating lung cancer from controls, with a recall (sensitivity) of 82%, precision of 90%, accuracy of 80% and F1-score of 86%. To further validate this model, TB data was introduced as a confounding disease, and the model achieved precision, recall, accuracy and F1-score of 88% each, in distinguishing lung cancer from TB. These findings address the inter-disease variability and underscores the reliability of the reported VOCs as potential biomarkers of lung cancer. This study establishes a new framework integrating machine learning and confounder elimination for biomarker confirmation.https://doi.org/10.1038/s41598-025-11365-4 |
| spellingShingle | Tlotlo Cassandra Setlhare Atlang Gild Mpolokang Emmanuel Flahaut George Chimowa Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework Scientific Reports |
| title | Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework |
| title_full | Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework |
| title_fullStr | Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework |
| title_full_unstemmed | Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework |
| title_short | Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework |
| title_sort | determination of lung cancer exhaled breath biomarkers using machine learning a new analysis framework |
| url | https://doi.org/10.1038/s41598-025-11365-4 |
| work_keys_str_mv | AT tlotlocassandrasetlhare determinationoflungcancerexhaledbreathbiomarkersusingmachinelearninganewanalysisframework AT atlanggildmpolokang determinationoflungcancerexhaledbreathbiomarkersusingmachinelearninganewanalysisframework AT emmanuelflahaut determinationoflungcancerexhaledbreathbiomarkersusingmachinelearninganewanalysisframework AT georgechimowa determinationoflungcancerexhaledbreathbiomarkersusingmachinelearninganewanalysisframework |